News

The company also announced its second quarter dividend policy, declaring a cash dividend of $0.30 per share. This impressive financial report shows that Jianpai Financial continues to maintain robust profitability amid a complex economic environment. Earnings per share of $0.82 exceeded market expectations, highlighting the company’s outstanding operational efficiency. The policy of continuous quarterly dividends demonstrates management’s strong commitment to shareholder returns. Notably, the newly announced quarterly dividend of $0.30 per share continues the company’s consistent and stable payout policy. This not only reflects the current strong cash flow, but also signals the board’s confidence in future earnings growth.

Both parties will leverage Guardant Health's Guardant Infinity™ liquid biopsy platform to jointly develop innovative companion diagnostic solutions, providing commercial support for Nuvalent’s targeted cancer therapies. This collaboration will focus on advancing precision medicine, accelerating Nuvalent’s clinical development of tumor-targeted drugs with Guardant Health’s advanced liquid biopsy technology. The Guardant Infinity™ platform enables comprehensive genomic analysis through blood samples, delivering critical data support for personalized treatment plans.This strategic partnership covers full-cycle support from drug development to commercialization, marking a new stage in the application of liquid biopsy technology for precision cancer treatment. Both sides will integrate their professional strengths in diagnostic technology and drug development, working together to provide cancer patients with more precise and efficient treatment solutions.

This brand revamp marks a critical step for the company in its strategic transformation from a traditional construction business to a diversified resource development sector. Of particular note, the company’s identification in the capital markets will also be updated simultaneously. Starting today, its securities will be traded on the Nasdaq exchange under the new ticker "Kazr". This change not only reflects the expansion of the company’s business scope but also demonstrates its ambition to pursue greater growth in the international resources sector. The brand upgrade and ticker change are expected to provide the company with broader international perspectives and financing channels, while also giving investors a clearer indicator of the company’s strategic positioning. With the new name and ticker in place, the market will closely monitor the resource development layout and capital operations of this transforming enterprise going forward.